Fat accumulation, mostly associated to Fatty Liver Disease, hypertension and imbalances in glico-lipidemic levels, leads to increased cardiovascular risk.
- Bergacyn® is a patented standardized extract of (Citrus Bergamia risso extract 20%, Cynara Cardunculus extract 10%).
- Bergacyn® has been shown to improve liver function in obese patients, thereby playing a role in counteracting dysregulation of glyco-lipemic metabolism.
Recently, in clinical settings, Bergacyn® has been shown to lead to reduction of body weight and to contribute in fat “browning”, reducing inflammation and pro-atherogenic mechanisms. This represents a right, natural and effective solution to antagonize the systemic impact of fat accumulation and to prevent cardiometabolic disorders.
Leave a Comment